Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis
Main Authors: | Morales, DR, Conover, MM, You, SC, Pratt, N, Kostka, K, Duarte-Salles, T, Fernández-Bertolín, S, Aragón, M, DuVall, SL, Lynch, K, Falconer, T, van Bochove, K, Sung, C, Matheny, ME, Lambert, CG, Nyberg, F, Alshammari, TM, Williams, AE, Park, RW, Weaver, J, Sena, AG, Schuemie, MJ, Rijnbeek, PR, Williams, RD, Lane, JCE, Prats-Uribe, A, Zhang, L, Areia, C, Krumholz, HM, Prieto-Alhambra, D, Ryan, PB, Hripcsak, G, Suchard, MA |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2020
|
Similar Items
-
Evaluating the comparative effectiveness and safety of repurposed drugs for COVID-19
by: Tan, EH, et al.
Published: (2022) -
Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network
by: Williams, RD, et al.
Published: (2022) -
Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety Surveillance
by: Arshad, F, et al.
Published: (2023) -
COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries
by: Tan, EH, et al.
Published: (2021) -
Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom
by: Recalde, M, et al.
Published: (2021)